Enhance your expertise with Spotlight On Multiple Myeloma, where you’ll find leading experts discuss the latest advancements in the diagnosis, treatment, and management of this rare blood cancer. So whether you're an oncologist, hematologist, or another provider involved in the care of patients with multiple myeloma, this series will keep you at the forefront of the field so you can make a meaningful impact on your patients' lives.
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
An Exploration of Multiple Myeloma Treatments
An Exploration of Multiple Myeloma Treatments
Fighting Multiple Myeloma with Triplet Therapy
Fighting Multiple Myeloma with Triplet Therapy
Improving the Prognoses of Multiple Myeloma
Improving the Prognoses of Multiple Myeloma
Multiple Myeloma: Current Treatment Modalities
Multiple Myeloma: Current Treatment Modalities
The Environmental Etiologies of Multiple Myeloma
The Environmental Etiologies of Multiple Myeloma
